Holen Sie sich die Stockscreener-App
0.8698
0.00%
0.00
Schlusskurs vom Vortag:
$0.8698
Offen:
$0.85
24-Stunden-Volumen:
25,891
Relative Volume:
0.13
Marktkapitalisierung:
$26.84M
Einnahmen:
$2.82M
Nettoeinkommen (Verlust:
$-13.47M
KGV:
-1.279
EPS:
-0.68
Netto-Cashflow:
$-13.61M
1W Leistung:
-1.16%
1M Leistung:
-22.00%
6M Leistung:
-10.34%
1J Leistung:
-29.29%
1-Tages-Spanne:
$0.85
$0.92
1-Wochen-Bereich:
$0.85
$0.92
52-Wochen-Spanne:
$0.551
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Vergleichen Sie NMTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1857 | 380.07M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.61 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.38 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.40 | 161.48M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
10.51 | 123.51M | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
Game-Changing Epilepsy Innovation: NeuroOne's FDA-Cleared Device Transforms Brain Treatment - StockTitan
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - Quantisnow
Breakthrough: First-Ever FDA-Cleared Device Transforms Epilepsy Treatment for 50M Patients - StockTitan
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
NeuroOne speeds up FDA submission for nerve ablation system - Investing.com
NeuroOne Speeds Up FDA Timeline: Revolutionary Facial Pain Treatment Could Hit Market Earlier Than Expected - StockTitan
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Barchart
Can NeuroOne's Upcoming Investor Presentation Signal New Growth in Neurological Tech? - StockTitan
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Earnings Call Transcript - MSN
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge - MSN
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Earnings call transcript: NeuroOne Medical sees Q1 2025 revenue surge By Investing.com - Investing.com Canada
NeuroOne Medical Technologies Corp Reports Q1 FY2025 Earnings: E - GuruFocus.com
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results - TradingView
Q1 Earnings Breakthrough: NeuroOne Hits Record $6.3M Revenue as Product Sales Triple - StockTitan
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. - EIN News
NeuroOne Medical Earnings Alert: Key Q1 2025 Results and Strategic Updates Coming February 12 - StockTitan
NeuroOne regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
NeuroOne regains Nasdaq compliance with share price - Investing.com
Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Inari Medical (NASDAQ:NARI) - Defense World
NeuroOne CEO shares company strategy in letter to shareholders - Investing.com
NeuroOne faces Nasdaq delisting over share price issue By Investing.com - Investing.com Australia
NeuroOne Medical Technologies Faces Delisting from Nasdaq Due to Non-Compliance - Defense World
NeuroOne faces Nasdaq delisting over share price issue - Investing.com India
NeuroOne Reports Record Revenue Boost in Q1 2025 - Yahoo Finance
NeuroOne Medical Revenue Surges 520% to Record $6.2M, Boosted by Zimmer Biomet Deal - Stock Titan
NeuroOne Medical Projects 190% Revenue Growth, Expands Zimmer Biomet Partnership - Stock Titan
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11: 00 a.m. EST - Marketscreener.com
NeuroOne Medical Projects 190% Revenue Growth, Sets Investor Webinar to Showcase Expansion - Stock Titan
NeuroOne Medical Technologies Reports Increased Product Revenue and Strategic Partnerships in 2024 - Defense World
NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ... - Yahoo Finance
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation - Investing.com Australia
Earnings call transcript: NeuroOne Q4 2024 sees stock surge on innovation By Investing.com - Investing.com South Africa
NeuroOne Medical Technologies Corp Reports Q4 Net Loss of $3.3 M - GuruFocus.com
NeuroOne Medical Projects 190% Revenue Growth for 2025 After Record-Breaking Year - StockTitan
Neuroone stock hits 52-week low at $0.56 amid market challenges - Investing.com
NeuroOne Medical Technologies Sets Q4 2024 Earnings Release Date - StockTitan
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing - The Globe and Mail
Nashville InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
Neuroone stock hits 52-week low at $0.59 amid market challenges - Investing.com
AWM Investment Company, Inc. Increases Stake in NeuroOne Medical Technologies Corp - GuruFocus.com
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event - Yahoo Finance
NeuroOne ends loan agreement with Growth Opportunity Funding - Investing.com
Zimmer Biomet to Present at Jefferies London Healthcare Conference - Marketscreener.com
NeuroOne agree $3m partnership with Zimmer Biomet - Yahoo! Voices
NeuroOne expands agreement with Zimmer Biomet for commercialisation of OneRF ablation system - NeuroNews International
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
Zimmer Biomet Holdings (NYSE:ZBH) Expands with NeuroOne Alliance and Z1 Hip System Launch - Yahoo Finance
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuroone Medical Technologies Corp-Aktie (NMTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Business Development Director |
Jun 06 '24 |
Sale |
0.88 |
2,189 |
1,918 |
295,035 |
| Christianson Mark | Business Development Director |
Jun 05 '24 |
Sale |
0.88 |
25,800 |
22,663 |
297,224 |
0.80%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):